Literature DB >> 19627248

Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007.

J Joukje Siebenga1, Harry Vennema, Du-Ping Zheng, Jan Vinjé, Bonita E Lee, Xiao-Li Pang, Eric C M Ho, Wilina Lim, Avinash Choudekar, Shobha Broor, Tamar Halperin, Nassar B G Rasool, Joanne Hewitt, Gail E Greening, Miao Jin, Zhao-Jun Duan, Yalda Lucero, Miguel O'Ryan, Marina Hoehne, Eckart Schreier, Rodney M Ratcliff, Peter A White, Nobuhiro Iritani, Gábor Reuter, Marion Koopmans.   

Abstract

BACKGROUND: Noroviruses (NoVs) are the most common cause of viral gastroenteritis. Their high incidence and importance in health care facilities result in a great impact on public health. Studies from around the world describing increasing prevalence have been difficult to compare because of differing nomenclatures for variants of the dominant genotype, GII.4. We studied the global patterns of GII.4 epidemiology in relation to its genetic diversity.
METHODS: Data from NoV outbreaks with dates of onset from January 2001 through March 2007 were collected from 15 institutions on 5 continents. Partial genome sequences (n=775) were collected, allowing phylogenetic comparison of data from different countries.
RESULTS: The 15 institutions reported 3098 GII.4 outbreaks, 62% of all reported NoV outbreaks. Eight GII.4 variants were identified. Four had a global distribution--the 1996, 2002, 2004, and 2006b variants. The 2003Asia and 2006a variants caused epidemics, but they were geographically limited. Finally, the 2001 Japan and 2001 Henry variants were found across the world but at low frequencies.
CONCLUSIONS: NoV epidemics resulted from the global spread of GII.4 strains that evolved under the influence of population immunity. Lineages show notable (and currently unexplained) differences in geographic prevalence. Establishing a global NoV network by which data on strains with the potential to cause pandemics can be rapidly exchanged may lead to improved prevention and intervention strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19627248     DOI: 10.1086/605127

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  268 in total

1.  Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan.

Authors:  Kazushi Motomura; Masaru Yokoyama; Hirotaka Ode; Hiromi Nakamura; Hiromi Mori; Tadahito Kanda; Tomoichiro Oka; Kazuhiko Katayama; Mamoru Noda; Tomoyuki Tanaka; Naokazu Takeda; Hironori Sato
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Chronic shedders as reservoir for nosocomial transmission of norovirus.

Authors:  Faizel H A Sukhrie; J Joukje Siebenga; Matthias F C Beersma; Marion Koopmans
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

4.  Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus.

Authors:  Verónica Costantini; LaDonna Grenz; Angela Fritzinger; David Lewis; Christianne Biggs; Antony Hale; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

5.  Molecular epidemiology of oyster-related human noroviruses and their global genetic diversity and temporal-geographical distribution from 1983 to 2014.

Authors:  Yongxin Yu; Hui Cai; Linghao Hu; Rongwei Lei; Yingjie Pan; Shuling Yan; Yongjie Wang
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

Review 6.  Burden of norovirus in healthcare facilities and strategies for outbreak control.

Authors:  A Kambhampati; M Koopmans; B A Lopman
Journal:  J Hosp Infect       Date:  2015-02-04       Impact factor: 3.926

7.  Complete nucleotide sequence of a norovirus GII.4 genotype: evidence for the spread of the newly emerged pandemic Sydney 2012 strain to China.

Authors:  Yuqi Huo; Ailing Cai; Hui Yang; Mingli Zhou; Jiaxin Yan; Dingxiang Liu; Shuo Shen
Journal:  Virus Genes       Date:  2013-11-27       Impact factor: 2.332

8.  Infectivity of GII.4 human norovirus does not differ between T-B-NK+ severe combined immunodeficiency (SCID) and non-SCID gnotobiotic pigs, implicating the role of NK cells in mediation of human norovirus infection.

Authors:  Thavamathi Annamalai; Zhongyan Lu; Kwonil Jung; Stephanie N Langel; Christopher K Tuggle; Jack C M Dekkers; Emily H Waide; Sukumar Kandasamy; Linda J Saif
Journal:  Virus Res       Date:  2019-05-02       Impact factor: 3.303

9.  Wipes coated with a singlet-oxygen-producing photosensitizer are effective against human influenza virus but not against norovirus.

Authors:  Katharina Verhaelen; Martijn Bouwknegt; Saskia Rutjes; Ana Maria de Roda Husman; Erwin Duizer
Journal:  Appl Environ Microbiol       Date:  2014-05-09       Impact factor: 4.792

10.  Influence of Environmental Conditions on Norovirus Presence in Mussels Harvested in Montenegro.

Authors:  Nevena Ilic; Branko Velebit; Vlado Teodorovic; Vesna Djordjevic; Nedjeljko Karabasil; Dragan Vasilev; Spomenka Djuric; Bojan Adzic; Mirjana Dimitrijevic
Journal:  Food Environ Virol       Date:  2017-04-24       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.